Raymond James increased stake in Encompass Health Co. (EHC) to 7.8%, and Q2 EPS beat consensus by $0.10.
Raymond James & Associates and other institutional investors increased their stakes in Encompass Health Co. (NYSE: EHC) in Q2, with Raymond James buying 9,701 shares, resulting in a 7.8% position. Encompass Health reported Q2 EPS of $1.11, beating the consensus estimate by $0.10, and announced a $0.17 quarterly dividend. Analysts from various firms, including Stephens, Barclays, and UBS Group, have given the company a buy or strong buy rating.
August 26, 2024
95 Articles